Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIGLETS Regimen for Peripheral T-Cell Lymphoma
NCT03071822Phase 4Unknown
- Sponsor
- The University of Hong Kong
- Start
- Feb 2017
- Primary completion
- Jul 2021
- Modality
- Orthosteric Ligands, Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of cisplatin, ifosfamide, gemcitabine, asparaginase escherichia coli, etoposide in peripheral T-cell lymphoma (PTCL), sponsored by The University of Hong Kong. Status: unknown.
02
Drugs
cisplatinifosfamidegemcitabineasparaginase escherichia colietoposide
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT03071822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03071822.